Archived Newsletters

  1. 10.09.25 -- Ivory Tower To CDMO: Universities Successfully Outsource Drug Development 10/9/2025
    10/09/25 Outsourced Pharma Newsletter
  2. 10.08.25 -- De-Risk And Accelerate Clinical Supply With Smarter CDMO Solutions 10/8/2025
    10/08/25 Outsourced Pharma Newsletter
  3. 10.08.25 -- FAQs On The Revised EU GMP Annex 1 10/8/2025

    10/08/25 Outsourced Pharma Newsletter

  4. 10.08.25 -- Execute Or Decay: Radiopharma's Outsourcing Reality 10/8/2025
    10/08/25 Outsourced Pharma Newsletter
  5. 10.07.25 -- Novel Preclinical Models To Advance Oncology Therapeutics 10/7/2025

    10/07/25 Outsourced Pharma Newsletter

  6. 10.07.25 -- Process Development Strategies For Lyophilized Products 10/7/2025

    10/07/25 Outsourced Pharma Newsletter

  7. 10.07.25 -- What FDA's Complete Response Letters (CRL) Say About Outsourcing 10/7/2025
    10/07/25 Outsourced Pharma Newsletter
  8. 10.06.25 -- Accelerating Cell & Gene Therapies With End-To-End CDMO Solutions 10/6/2025
    10/06/25 Outsourced Pharma Newsletter
  9. 10.06.25 -- STREAM Edition: Advice For Managing Multiple CDMOs 10/6/2025

    10/06/25 Outsourced Pharma Newsletter

  10. 10.06.25 -- You're In Charge Of Strategic Sourcing? What's That Actually Mean? 10/6/2025
    10/06/25 Outsourced Pharma Newsletter